Cargando…
Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients
Beta-blockers include a large spectrum of drugs with various specific characteristics, and a well-known cardioprotective efficacy. They are recommended in heart failure, hypertension and arrhythmia. Their use in chronic hemodialysis patients is still controversial, mainly because of the lack of spec...
Autores principales: | Haddiya, Intissar, Valoti, Siria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578177/ https://www.ncbi.nlm.nih.gov/pubmed/37849744 http://dx.doi.org/10.2147/IJNRD.S414774 |
Ejemplares similares
-
Current Knowledge of Vaccinations in Chronic Kidney Disease Patients
por: Haddiya, Intissar
Publicado: (2020) -
The current status of beta blockers’ use in the management of hypertension
por: Akbar, Shahid, et al.
Publicado: (2014) -
Syndrome d’antidiurèse inappropriée néphrogénique
por: Nawal, Benabdellah, et al.
Publicado: (2019) -
Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
por: Tomiyama, Hirofumi, et al.
Publicado: (2014) -
Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)